PITTSBURGH--(BUSINESS WIRE)--Helomics™ Corporation, a privately-held comprehensive personalized healthcare company that provides comprehensive tumor profiling utilizing proprietary live cell and fixed cell products as well as other lab services, announced today that the American Medical Association’s CPT® Editorial Board has awarded Helomics’ flagship live cell assay, ChemoFx®, its own unique CPT codes. To receive a unique CPT code, a product must satisfy a stringent set of criteria and undergo